-transparent.png){kind=logo}
A somatostatin analogue, compound SMS 201-995, was used to treat postprandial hypotension in a patient with autonomic neuropathy. Prior to treatment, the patient's mean blood pressure decreased 50 to 80 mm Hg after each meal, resulting in frequent loss of consciousness. Subcutaneous administration of low doses of compound SMS 201-995 (12 to 16 micrograms) prevented the postprandial hypotension. The therapeutic benefits of SMS 201-995 dissipated after a few hours, however, which made it necessary to administer the drug with each meal. No adverse effects of this agent were noted over a nine-month treatment period. Compound SMS 201-995 provided safe and effective therapy for postprandial hypotension.
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
February 1989,
Harefuah,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
September 1987,
The American journal of medicine,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
January 1994,
G.E.N,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
June 1990,
The British journal of surgery,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
July 1988,
The British journal of surgery,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
October 1988,
Endocrinologia japonica,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
November 1990,
Archives of internal medicine,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
October 1996,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
November 1988,
Surgery,
R D Hoeldtke, and
G Boden, and
T M O'Dorisio
April 1985,
Lancet (London, England),
